MAIA Biotechnology Inc (MAIA): Next-Year EPS Estimate 315.38%
As of 2026-06-04, MAIA Biotechnology Inc (MAIA) has a next-year EPS growth estimate of 315.38%.
Analyst estimates for MAIA have remained steady in the most recent observable window, with next-year EPS growth projected at 315.38%. Current-year growth stands at 25.71%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 315.38%
- EPS growth this year
- 25.71%
- EPS next quarter (est)
- -$0.11
- Last price
- $1.50
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 315.38% | 25.71% | -$0.11 | $1.50 |
| 2026-06-03 | 315.38% | 25.71% | -$0.11 | $1.43 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is MAIA Biotechnology Inc's next-year EPS growth estimate?▾
As of 2026-06-04, MAIA Biotechnology Inc (MAIA) has a next-year EPS growth estimate of 315.38%, based on analyst consensus.
What sector and industry does MAIA Biotechnology Inc belong to?▾
MAIA Biotechnology Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MAIA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. MAIA Biotechnology Inc (MAIA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports